<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02797535</url>
  </required_header>
  <id_info>
    <org_study_id>COVGIBD0533</org_study_id>
    <nct_id>NCT02797535</nct_id>
  </id_info>
  <brief_title>GI Fluids Collection for an Ex-Vivo Development of Ingestible Capsule Devices With Real Time Biosensors</brief_title>
  <acronym>CLARINET</acronym>
  <official_title>GI Fluids Collection for an Ex-Vivo Development of Ingestible Capsule Devices With Real Time Biosensors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic - MITG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic - MITG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Up to 500 subjects undergoing standard endoscopy / pouchoscopy, or having ileostomy or
      colostomy bags or having an ileal pouch and who meet the eligibility criteria will be
      enrolled to this study during up to three years at up to 4 clinical sites. GI fluids samples
      will be collected from: (i) fluids suctioned during standard endoscopy procedures /
      pouchoscopy, (ii) from ileostomy/colostomy bags removed for bag replacement and (iii) from
      stool samples collected by patients after pouch surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Characterization and quantification of small molecules- and protein biomarkers of GI diseases will be performed. Examples of such biomarkers include - calprotectin, lactoferrin, albumin, hemoglobin, CEA, CA19-9, CA 72-4, LYVE-1, REG1A, TFF1 and ammonia.</measure>
    <time_frame>3 years</time_frame>
    <description>The concentration of the biomarkers in the collected fluids from different parts of the GI will be determined by quantitative assays - such as ELISA or lateral flow immunoassay or mass spectrometry. Concentration will be determined in mg/ml.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Chronic Inflammatory Small Bowel Disease</condition>
  <arm_group>
    <arm_group_label>GI fluids samples collection</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>GI fluids samples will be collected from: (i) fluids suctioned during standard endoscopy procedures / pouchoscopy, (ii) from ileostomy/colostomy bags removed for bag replacement and (iii) from stool samples collected by patients after pouch surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopy procedures</intervention_name>
    <description>GI fluids samples will be collected from: (i) fluids suctioned during standard endoscopy procedures / pouchoscopy, (ii) from ileostomy/colostomy bags removed for bag replacement and (iii) from stool samples collected by patients after pouch surgery.</description>
    <arm_group_label>GI fluids samples collection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects ages 18-75 years

          -  Subjects referred to endoscopic procedures gastroscopy, esophagogastroduodenoscopy
             (EGD), colonoscopy, single balloon or double balloon enteroscopy Or Subjects having
             ileostomy or colostomy bags Or Subjects having an ileal pouch

          -  Subjects agree to sign consent form

        Exclusion Criteria:

          -  Patients has any medical condition that requires special handling of body fluids
             beyond routine infection control measures (i.e. standard surgical gloves)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rami Eliakim, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sheba Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Inbal Eyal</last_name>
    <phone>+972-4-9097970</phone>
    <email>inbal.eyal@medtronic.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat-Gan</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rami Eliakim, Prof.</last_name>
      <phone>+972 3 530 3810</phone>
      <email>Prof. Eliakim Abraham &lt;Abraham.Eliakim@sheba.health.gov.il&gt;</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Tel-Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel-Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erwin Santo, Dr.</last_name>
      <phone>036973970</phone>
      <email>Jenny Rutenburg &lt;jennyr@tlvmc.gov.il&gt;</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2016</study_first_submitted>
  <study_first_submitted_qc>June 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2016</study_first_posted>
  <last_update_submitted>April 18, 2018</last_update_submitted>
  <last_update_submitted_qc>April 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

